Oncofertility and COVID-19: At the Crossroads between Two Time-Sensitive Fields.

Valentin Nicolae VarlasRoxana Georgiana BorșAnca Lucia PopBogdana Adriana NăsuiNicolae BacalbasaRoxana BohîlțeaEmilia Maria VladareanuCorina Manolea

Published in: Journal of clinical medicine (2022)

Fertility preservation (FP) should not be discontinued, but instead practiced with adjustments to prevent SARS-CoV-2 transmission. The increased risk of SARS-CoV-2 infection in cancer patients requires screening for COVID-19 before FP procedures, among both patients and medical staff in FP clinics, to prevent infection that would rapidly worsen the condition and lead to severe complications.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
primary care
healthcare
prognostic factors
peritoneal dialysis
early onset
risk factors
young adults
drug induced